Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.
Recent research suggests that people who take psilocybin in carefully run therapy sessions often report feeling more connected to others afterwards. These reports come from interviews, small clinical trials, and reviews, and they usually describe changes in how people think about themselves and their relationships. However, most studies are early-stage, often combine the drug with therapy and a special setting, and use small or selected groups of people, so we do not yet have strong proof that psilocybin reliably fixes social disconnection for everyone.
This paper describes psychedelic-assisted psychotherapy, which means giving drugs like ketamine, MDMA, psilocybin, LSD or ibogaine together with guided therapy. The authors say this approach has shown promising safety and benefits so far, even for people who did not get better with usual treatments. They also argue that these therapies…
